| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |